CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' (DEFICIT) EQUITY (UNAUDITED) - USD ($) $ in Thousands | Total | Common Stock | Accumulated Deficit |
Balance, beginning of period at Jan. 29, 2022 | $ 81,126 | $ 175,856 | $ (94,730) |
Balance, beginning of period (in shares) at Jan. 29, 2022 | | 12,631,347 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | 16 | $ 16 | |
Exercise of stock options (in shares) | | 2,705 | |
Restricted stock issued | | 797,849 | |
Net share settlement of stock options and restricted stock units | (2,375) | $ (2,375) | |
Net share settlement of stock options and restricted stock units (in shares) | | (224,320) | |
Stock-based compensation expense | 548 | $ 548 | |
Repurchase and retirement of common stock | (6,253) | | (6,253) |
Repurchase and retirement of common stock (in shares) | | (479,966) | |
Net Income (Loss) | (7,855) | | (7,855) |
Balance, end of period at Apr. 30, 2022 | 65,207 | $ 174,045 | (108,838) |
Balance, end of period (in shares) at Apr. 30, 2022 | | 12,727,615 | |
Balance, beginning of period at Jan. 29, 2022 | 81,126 | $ 175,856 | (94,730) |
Balance, beginning of period (in shares) at Jan. 29, 2022 | | 12,631,347 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | $ 16 | | |
Repurchase and retirement of common stock (in shares) | (479,966) | | |
Net Income (Loss) | $ (33,560) | | |
Balance, end of period at Jul. 30, 2022 | $ 40,111 | $ 174,654 | (134,543) |
Balance, end of period (in shares) at Jul. 30, 2022 | 12,754,368 | 12,754,368 | |
Balance, beginning of period at Apr. 30, 2022 | $ 65,207 | $ 174,045 | (108,838) |
Balance, beginning of period (in shares) at Apr. 30, 2022 | | 12,727,615 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Restricted stock issued | | 28,574 | |
Net share settlement of stock options and restricted stock units | (8) | $ (8) | |
Net share settlement of stock options and restricted stock units (in shares) | | (1,821) | |
Stock-based compensation expense | $ 617 | $ 617 | |
Repurchase and retirement of common stock (in shares) | 0 | | |
Net Income (Loss) | $ (25,705) | | (25,705) |
Balance, end of period at Jul. 30, 2022 | $ 40,111 | $ 174,654 | (134,543) |
Balance, end of period (in shares) at Jul. 30, 2022 | 12,754,368 | 12,754,368 | |
Balance, beginning of period at Jan. 28, 2023 | $ 29,773 | $ 175,450 | (145,677) |
Balance, beginning of period (in shares) at Jan. 28, 2023 | 12,754,368 | 12,754,368 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Restricted stock issued | | 86,824 | |
Net share settlement of stock options and restricted stock units | $ (76) | $ (76) | |
Net share settlement of stock options and restricted stock units (in shares) | | (28,294) | |
Stock-based compensation expense | 490 | $ 490 | |
Net Income (Loss) | (12,107) | | (12,107) |
Balance, end of period at Apr. 29, 2023 | 18,080 | $ 175,864 | (157,784) |
Balance, end of period (in shares) at Apr. 29, 2023 | | 12,812,898 | |
Balance, beginning of period at Jan. 28, 2023 | $ 29,773 | $ 175,450 | (145,677) |
Balance, beginning of period (in shares) at Jan. 28, 2023 | 12,754,368 | 12,754,368 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | $ 0 | | |
Repurchase and retirement of common stock (in shares) | 0 | | |
Net Income (Loss) | $ (31,471) | | |
Balance, end of period at Jul. 29, 2023 | $ (1,160) | $ 175,988 | (177,148) |
Balance, end of period (in shares) at Jul. 29, 2023 | 12,917,373 | 12,917,373 | |
Balance, beginning of period at Apr. 29, 2023 | $ 18,080 | $ 175,864 | (157,784) |
Balance, beginning of period (in shares) at Apr. 29, 2023 | | 12,812,898 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Restricted stock issued | | 104,475 | |
Stock-based compensation expense | $ 124 | $ 124 | |
Repurchase and retirement of common stock (in shares) | 0 | | |
Net Income (Loss) | $ (19,364) | | (19,364) |
Balance, end of period at Jul. 29, 2023 | $ (1,160) | $ 175,988 | $ (177,148) |
Balance, end of period (in shares) at Jul. 29, 2023 | 12,917,373 | 12,917,373 | |